Macquarie Group LTD Adaptive Biotechnologies Corp Transaction History

Macquarie Group LTD

$85.1 Billion
Q2 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$2.88 - $4.8 $6,085 - $10,142	-2,113 Reduced 1.71%	121,185 $389,000
Q4 2023 Feb 14, 2024	BUY	$3.46 - $5.33 $62,041 - $95,572	17,931 Added 17.02%	123,298 $604,000
Q3 2023 Nov 14, 2023	BUY	$5.07 - $8.44 $10,418 - $17,344	2,055 Added 1.99%	105,367 $574,000
Q2 2023 Aug 14, 2023	BUY	$6.19 - $8.78 $97,684 - $138,557	15,781 Added 18.03%	103,312 $693,000
Q1 2023 May 15, 2023	BUY	$7.8 - $10.11 $231,309 - $299,812	29,655 Added 51.24%	87,531 $772,000
Q4 2022 Feb 21, 2023	SELL	$6.26 - $9.34 $117,662 - $175,554	-18,796 Reduced 24.51%	57,876 $442,000
Q3 2022 Nov 14, 2022	SELL	$6.5 - $12.67 $8,599 - $16,762	-1,323 Reduced 1.7%	76,672 $553,000
Q2 2022 Aug 15, 2022	SELL	$6.4 - $14.73 $2,246 - $5,170	-351 Reduced 0.45%	77,995 $631,000
Q1 2022 May 16, 2022	BUY	$10.12 - $28.9 $35,885 - $102,479	3,546 Added 4.74%	78,346 $1.09 Million
Q4 2021 Feb 11, 2022	BUY	$25.17 - $36.85 $310,698 - $454,876	12,344 Added 19.76%	74,800 $2.1 Million
Q3 2021 Nov 12, 2021	BUY	$30.02 - $39.87 $221,967 - $294,798	7,394 Added 13.43%	62,456 $2.12 Million
Q2 2021 Aug 13, 2021	BUY	$32.22 - $44.59 $146,697 - $203,018	4,553 Added 9.01%	55,062 $2.25 Million
Q1 2021 May 14, 2021	BUY	$37.26 - $67.74 $404,159 - $734,775	10,847 Added 27.35%	50,509 $2.03 Million
Q4 2020 Feb 16, 2021	SELL	$45.01 - $65.47 $148,893 - $216,574	-3,308 Reduced 7.7%	39,662 $2.35 Million
Q3 2020 Nov 13, 2020	SELL	$35.79 - $48.81 $112,774 - $153,800	-3,151 Reduced 6.83%	42,970 $2.09 Million
Q2 2020 Aug 11, 2020	BUY	$24.95 - $48.38 $96,581 - $187,278	3,871 Added 9.16%	46,121 $2.23 Million
Q1 2020 May 15, 2020	BUY	$16.96 - $34.16 $198,381 - $399,569	11,697 Added 38.28%	42,250 $1.17 Million
Q4 2019 Feb 14, 2020	BUY	$24.56 - $32.8 $750,381 - $1 Million	30,553 New	30,553 $914,000

Others Institutions Holding ADPT

# of Institutions

187

Shares Held

152M

Call Options Held

8.4K

Put Options Held

56K

Viking Global Investors LP

30M
Shares

$150 Million
0.43% of portfolio
Rubric Capital Management LP New York, NY

14M
Shares

$70 Million
1.5% of portfolio
Black Rock Inc. New York, NY

11.7M
Shares

$58.3 Million
0.0% of portfolio
Matrix Capital Management Company, LP Waltham, MA

11.6M
Shares

$57.9 Million
0.32% of portfolio
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

11.4M
Shares

$57.1 Million
0.38% of portfolio

View Full List

About Adaptive Biotechnologies Corp

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $714M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

More about ADPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.

Account